Shockwave Therapy for Lower Limb Conditions
Using shockwave to treat common conditions of the lower limb and feet
Course Details
Open to physiotherapists, osteopaths, podiatrists, sports therapists, chiropractors & GPs, this one-day course aims to train those with previous practical experience of shockwave therapy who would like to expand upon their ability to effectively treat common foot and lower limb conditions.
The course will involve both radial and focused shockwave therapy as well as EMTT.
Stuart covers shockwave for treating the most common indications such as plantar fasciitis and chronic tendinopathies but also includes shockwave for first joint pain, forefoot Morton’s neuroma, the ankle complex, shin splints, myofascial calf pain, dorsal foot and calcaneal bursitis. He will share case studies and his own recipes for treatment success.
The day is split between theory and practical sessions to ensure practical experience is gained with the device and to explore this revolutionary treatment that has helped clinics develop effective programs for their patients.
The course will begin at 9am and end at approximately 4pm and will be hosted in either our London or Liverpool training centres. There will be a break around midday for lunch, which is provided. Any dietary requirements will be requested after you book.
There will be time once the course ends to ask any specific questions about shockwave therapy or related topics.
Course taught by
Learning Outcomes:
History of shockwave therapy (mechanisms, indications and contraindications) in the context of lower limbs.
How to manage and treat the main areas of lower limb chronic tendinopathy and other key conditions.
How current evidence is used to determine clinic protocols and how to apply them to your treatment sessions.
Gaining of hands-on experience from shockwave practicals and demos.
Patient selection.
How shockwave is used in conjunction with exercise and loading.
Join the Waiting List
Can’t see a date that you are available for?
Sign up to our waiting list to be the first to hear about our Q2 dates.
